多模式镇痛与心脏手术加速康复结局:观察性队列研究
该回顾性队列研究利用胸外科医师学会数据库2020至2023年数据,纳入17371例择期冠脉搭桥、瓣膜或联合手术成人患者,其中89.3%接受多模式镇痛。调整混杂因素后,多模式镇痛与术后第3天最大疼痛评分无关,但与初始机械通气时间缩短相关;对乙酰氨基酚使用与谵妄风险降低相关,区域神经阻滞与计划外再插管风险增加相关。
要点
- 多模式镇痛未降低术后第3天最大疼痛评分。
- 多模式镇痛与初始机械通气时间缩短约30分钟相关。
- 对乙酰氨基酚与谵妄风险降低相关,区域阻滞与再插管风险增加相关。
核心结论
- 多模式镇痛与主要结局术后第3天最大疼痛评分降低无关,但与更快的拔管相关。
- 需更大规模的前瞻性观察和随机对照试验研究单个镇痛药物以优化ERACS方案。
研究设计与样本
- 回顾性队列研究,使用胸外科医师学会数据库2020至2023年数据。
- 纳入择期冠脉搭桥、瓣膜或联合冠脉搭桥-瓣膜手术成人患者,共17371例符合条件,其中15515例(89.3%)接受多模式镇痛。
- 采用线性混合效应回归模型和广义线性混合效应回归模型控制混杂因素。
主要发现
- 调整混杂因素后,多模式镇痛与术后第3天最大疼痛评分无关(b = -0.07,95%CI -0.32至0.18,P = .57)。
- 多模式镇痛与初始机械通气时间相关(b = 0.45小时,95%CI 0.04-0.86,P = .03);未接受多模式镇痛者平均初始机械通气时间长约30分钟。
- 初始机械通气时间随多模式镇痛药物数量增加而减少:1种药物b = -0.33小时(95%CI -76至-0.10,P = .14);5种药物Est = -1.98小时(95%CI -3.79至-0.18,P = .03)。
- 对乙酰氨基酚使用与谵妄风险降低相关(OR = 0.75,95%CI 0.57-0.94,P = .02)。
- 区域神经阻滞使用与计划外再插管风险增加相关(OR = 1.59,95%CI 1.12-2.27,P = .01)。
临床怎么用
- 多模式镇痛可能有助于加快心脏术后拔管,但不应预期其显著降低术后第3天疼痛评分。
- 对乙酰氨基酚可能降低谵妄风险,区域神经阻滞需权衡再插管风险。
局限性
- 回顾性研究设计,可能存在残余混杂。
- 多模式镇痛与初始机械通气时间的关联在药物数量分析中部分未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimodal analgesia, the use of more than 1 pharmacologic agent targeting different receptors, is a cornerstone of enhanced recovery after cardiac surgery (ERACS), but there are limited studies to support its efficacy. We aimed to explore associations between multimodal analgesia and enhanced recovery outcomes after cardiac surgery. METHODS: We performed a retrospective cohort study using data from the Society of Thoracic Surgeons database from 2020 to 2023. Adults undergoing elective coronary artery bypass grafting (CABG), valve, or combined CABG-valve surgery were included. Our primary hypothesis was that multimodal analgesia would be associated with a lower maximum postoperative pain score on postoperative day 3 (POD3). Secondarily, we hypothesized that multimodal analgesia would be associated with reduced mechanical ventilation hours, intensive care unit stay, delirium, pneumonia, and reintubation. Linear mixed-effects regression models and generalized linear mixed-effects regression models were used to examine the extent the use of multimodal analgesia was associated with study outcomes after controlling for confounders. RESULTS: Over the 4-year study period, there were 17,371 eligible cardiac surgical cases and 15,515 patients (89.3%) received multimodal analgesia. There was no association between multimodal analgesia use and maximum postoperative pain score on POD3 ( b = -0.07, 95% confidence interval [CI], -0.32 to 0.18, P = .57), after adjusting for confounders. There was an association between multimodal analgesia use and initial mechanical ventilation hours ( b = 0.45 hours, 95% CI, 0.04-0.86, P = .03). Compared to patients who received multimodal analgesia, those who did not receive multimodal analgesia had approximately 30 minutes longer of initial mechanical ventilation time on average. Initial mechanical ventilation time decreased as the number of multimodal analgesic increased ( b = -0.33 hours, 95% CI, -76 to -0.10, P = .14) for 1 multimodal analgesic; Est = -1.98 hours, 95% CI, -3.79 to -0.18, P = .03 for 5 multimodal analgesics). Acetaminophen use was associated with a reduced likelihood of delirium (odds ratio [OR] = 0.75, 95% CI, 0.57-0.94, P = .02), while use of a regional nerve block was associated with increased likelihood of unplanned reintubation (OR = 1.59, 95% CI, 1.12-2.27, P = .01). CONCLUSIONS: In this retrospective study, multimodal analgesia was not associated with the primary outcome of reduction in maximum pain score but was associated with more rapid extubation. Larger prospective observational and randomized controlled trials of individual analgesic drugs are needed to optimize ERACS protocols.
引用
- Kleiman AM, Tsang S, Walters SM, et al. Multimodal Analgesia and Enhanced Recovery Outcomes in Cardiac Surgical Patients: An Observational Cohort Study. Anesth Analg. 2025. PMID: 40560779. doi:10.1213/ANE.0000000000007612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。